Maria Cotrina
Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Gap Junctions | 8 | 1998 | 15 |
Why?
|
Astrocytes | 10 | 1998 | 62 |
Why?
|
Connexin 43 | 6 | 1998 | 14 |
Why?
|
Connexins | 5 | 1998 | 18 |
Why?
|
Calcium Signaling | 6 | 1999 | 52 |
Why?
|
Brain | 4 | 1998 | 305 |
Why?
|
Adenosine Triphosphate | 5 | 1998 | 121 |
Why?
|
Cell Communication | 4 | 2000 | 72 |
Why?
|
Neurons | 3 | 1998 | 195 |
Why?
|
Aging | 2 | 2001 | 275 |
Why?
|
Brain Ischemia | 3 | 1998 | 45 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2000 | 11 |
Why?
|
Calcium | 5 | 1998 | 208 |
Why?
|
Nerve Growth Factor | 1 | 2000 | 20 |
Why?
|
Cerebral Cortex | 2 | 1998 | 108 |
Why?
|
Neuroglia | 1 | 2000 | 49 |
Why?
|
Adenosine Triphosphatases | 1 | 1998 | 43 |
Why?
|
Apoptosis | 3 | 1998 | 265 |
Why?
|
Animals | 14 | 1998 | 1031 |
Why?
|
Actins | 1 | 1998 | 112 |
Why?
|
Rats | 8 | 1998 | 530 |
Why?
|
Cells, Cultured | 7 | 1998 | 447 |
Why?
|
Cell Movement | 2 | 2004 | 163 |
Why?
|
Signal Transduction | 3 | 1998 | 313 |
Why?
|
Cell Adhesion | 3 | 2002 | 113 |
Why?
|
Tumor Cells, Cultured | 4 | 1998 | 233 |
Why?
|
Rosaniline Dyes | 1 | 2009 | 8 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 2009 | 8 |
Why?
|
Mice | 4 | 1998 | 623 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2004 | 68 |
Why?
|
Glioma | 2 | 1998 | 51 |
Why?
|
Receptor, EphB2 | 1 | 2008 | 1 |
Why?
|
Spinal Cord Injuries | 1 | 2009 | 34 |
Why?
|
Thapsigargin | 2 | 1998 | 18 |
Why?
|
Hippocampus | 2 | 1998 | 83 |
Why?
|
MAP Kinase Signaling System | 1 | 2008 | 56 |
Why?
|
Microscopy, Fluorescence | 2 | 1998 | 137 |
Why?
|
Calcium Channels | 1 | 2008 | 52 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 208 |
Why?
|
Transfection | 4 | 1998 | 237 |
Why?
|
Humans | 11 | 1998 | 1856 |
Why?
|
Receptors, Eph Family | 1 | 2004 | 1 |
Why?
|
Ephrins | 1 | 2004 | 1 |
Why?
|
Neuroprotective Agents | 2 | 2000 | 60 |
Why?
|
Fluorescent Dyes | 3 | 1998 | 115 |
Why?
|
Immunohistochemistry | 3 | 1999 | 355 |
Why?
|
Synaptic Transmission | 1 | 2002 | 58 |
Why?
|
Ectoderm | 1 | 2000 | 9 |
Why?
|
Neoplasms, Experimental | 1 | 2002 | 72 |
Why?
|
Energy Metabolism | 1 | 2002 | 80 |
Why?
|
Receptor, trkA | 1 | 2000 | 6 |
Why?
|
Phosphorylation | 2 | 1998 | 224 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2000 | 3 |
Why?
|
Rats, Sprague-Dawley | 2 | 1998 | 257 |
Why?
|
Chick Embryo | 1 | 2000 | 62 |
Why?
|
Purinergic Antagonists | 1 | 2000 | 3 |
Why?
|
Embryonic and Fetal Development | 1 | 2000 | 52 |
Why?
|
Nervous System | 1 | 2000 | 52 |
Why?
|
Mesoderm | 1 | 2000 | 35 |
Why?
|
Organ Specificity | 1 | 2000 | 104 |
Why?
|
Meninges | 1 | 2000 | 12 |
Why?
|
Nerve Growth Factors | 1 | 2000 | 43 |
Why?
|
Suramin | 1 | 1998 | 9 |
Why?
|
Cytochalasin D | 1 | 1998 | 16 |
Why?
|
Myosin-Light-Chain Kinase | 1 | 1998 | 12 |
Why?
|
Apyrase | 1 | 1998 | 12 |
Why?
|
Brain Neoplasms | 1 | 2002 | 116 |
Why?
|
Ionophores | 1 | 1998 | 15 |
Why?
|
Glioblastoma | 1 | 1998 | 44 |
Why?
|
Isoquinolines | 1 | 1998 | 34 |
Why?
|
Second Messenger Systems | 1 | 1998 | 19 |
Why?
|
Organ Culture Techniques | 1 | 1998 | 42 |
Why?
|
Glucocorticoids | 1 | 1999 | 107 |
Why?
|
Microtubules | 1 | 1998 | 38 |
Why?
|
HeLa Cells | 1 | 1998 | 107 |
Why?
|
Cerebral Infarction | 1 | 1998 | 36 |
Why?
|
Protons | 1 | 1998 | 30 |
Why?
|
Animals, Newborn | 1 | 1998 | 175 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1998 | 176 |
Why?
|
Cell Survival | 1 | 1998 | 229 |
Why?
|
Mice, Inbred C57BL | 1 | 2001 | 318 |
Why?
|
Cell Membrane | 1 | 1998 | 170 |
Why?
|
Enzyme Inhibitors | 1 | 1998 | 216 |
Why?
|
Indicators and Reagents | 2 | 1999 | 79 |
Why?
|
Mice, Knockout | 1 | 1998 | 265 |
Why?
|
Time Factors | 3 | 1999 | 896 |
Why?
|
Disease Models, Animal | 2 | 2008 | 349 |
Why?
|
Oxidative Stress | 1 | 1998 | 119 |
Why?
|
Permeability | 2 | 1999 | 52 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2009 | 9 |
Why?
|
Receptors, Purinergic P2 | 1 | 2009 | 13 |
Why?
|
Ephrin-B1 | 1 | 2008 | 1 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2008 | 5 |
Why?
|
Feedback, Physiological | 1 | 2008 | 26 |
Why?
|
Recovery of Function | 1 | 2009 | 91 |
Why?
|
Endocytosis | 1 | 2008 | 38 |
Why?
|
Protein Kinase Inhibitors | 1 | 2008 | 59 |
Why?
|
Spinal Cord | 1 | 2009 | 94 |
Why?
|
RNA Interference | 1 | 2008 | 75 |
Why?
|
RNA, Small Interfering | 1 | 2008 | 116 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1999 | 431 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2008 | 73 |
Why?
|
Recombinant Fusion Proteins | 1 | 2008 | 189 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 128 |
Why?
|
Neural Crest | 1 | 2004 | 10 |
Why?
|
rho GTP-Binding Proteins | 1 | 2004 | 16 |
Why?
|
Body Patterning | 1 | 2004 | 22 |
Why?
|
Cell Line | 1 | 2008 | 375 |
Why?
|
Male | 2 | 1998 | 1553 |
Why?
|
Neovascularization, Physiologic | 1 | 2004 | 68 |
Why?
|
Cell Aggregation | 1 | 2002 | 25 |
Why?
|
Rats, Wistar | 1 | 2002 | 75 |
Why?
|
Neoplasm Transplantation | 1 | 2002 | 67 |
Why?
|
Patch-Clamp Techniques | 1 | 2002 | 47 |
Why?
|
Neoplasm Invasiveness | 1 | 2002 | 105 |
Why?
|
Structure-Activity Relationship | 1 | 2002 | 124 |
Why?
|
Antibodies | 1 | 2002 | 159 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2002 | 126 |
Why?
|
Fura-2 | 1 | 1999 | 15 |
Why?
|
Methylprednisolone | 1 | 1999 | 41 |
Why?
|
Female | 1 | 1998 | 1643 |
Why?
|
Hormone Antagonists | 1 | 1999 | 26 |
Why?
|
Mifepristone | 1 | 1999 | 30 |
Why?
|
Dexamethasone | 1 | 1999 | 109 |
Why?
|
Reaction Time | 1 | 1998 | 81 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 1998 | 71 |
Why?
|
